Soo Kim concentrates her practice on large complex litigation that spans multiple industries and practice groups. She is a member of Robinson+Cole’s Managed Care + Employe Benefit Litigation Group. Ms. Kim’s practice predominantly focuses on defending pharmaceutical and medical device manufacturers in mass tort litigation. She has managed the administration of settlements of pharmaceutical mass tort litigation in the United States and Canada. Ms. Kim also defends commercial clients in health care and toxic tort litigation. Read her full rc.com bio here.
The Ninth Circuit recently issued two decisions in Dorman v. Charles Schwab Corp.: the first overrules the decision in Amaro v. Continental Can. Co., 724 F.2d 747 (9th Cir. 1984) (Dorman, – F.3d –, No. 18-15281, 2019 WL 3926990 (9th Cir. Aug. 20, 2019) (slip op.) (“Dorman I”)); and the second concludes that an individual’s … Continue Reading
The Second Circuit recently held that alleged misrepresentations by a “ministerial” plan representative about plan benefits will not support a claim for breach of fiduciary duty if the SPD clearly provides “complete and accurate” information, but might support a claim for breach of fiduciary duty if the SPD does not. In re DeRogatis, 16-977-cv, 16-3549-cv … Continue Reading
The Colorado Supreme Court’s decisions upholding the dismissal of claims against two separate disability plans under ERISA may be under review by the Supreme Court, following submission of the joint petition for a writ of certiorari filed in Olivar v. Public Serv. Employee Credit Union Long Term Disability Plan and Burton v. Colorado Access a/k/a … Continue Reading